Aug 3, 2017

Stryker adds former health system CEO (and customer) to board

Christy Radecic / AP

Medical device manufacturer Stryker has added Mary Brainerd to its board of directors. Brainerd, the retired CEO of HealthPartners, a $6 billion not-for-profit hospital and health insurance system in Minnesota, will get an annual $60,000 retainer fee and about $500,000 worth of stock options, according to a federal filing posted by Stryker.

The kicker: Stryker sold $17 million worth of medical devices to HealthPartners between January 2016 through May 2017.

Why it matters: Many health care executives — at both not-for-profit and publicly traded companies — hold cushy positions on the boards of other companies. That isn't problematic in a vacuum, but it could raise questions about conflicts of interest if executives' organizations do business with the companies where they hold board power.

Update: A HealthPartners spokesperson said the system uses "competitive bidding processes for major contracts, and these are complex, evidence-based decisions made by purchasing leadership, not the CEO."

More industry examples: Brainerd's appointment to Stryker's board isn't unique. Here are some other examples of current and former not-for-profit health care executives who sit on the boards of for-profit health care companies that could have business arrangements:

  • Lloyd Dean, CEO of Dignity Health: former board director at Navigant, a health care consulting firm. (More controversially, Dean has been a long-time board member at Wells Fargo.)
  • Kevin Lofton, CEO of Catholic Health Initiatives: board director at Gilead Sciences, a pharmaceutical company known for its high-priced HIV and hepatitis C medicines.
  • William Roper, CEO of the University of North Carolina Health Care: board director at dialysis chain DaVita and pharmacy benefit manager Express Scripts.
  • Martha Marsh, former CEO of Stanford Health Care: board director at medical device company Edwards Lifesciences, medical supplies provider Owens & Minor and health care staffing firm AMN Healthcare.
  • Nancy Schlichting, former CEO of Henry Ford Health System: board director at pharmacy chain Walgreens Boots Alliance.
  • John Forsyth, CEO of Wellmark: board director at medical supplies and drug company Baxter International.
  • Denis Cortese, former CEO of Mayo Clinic: board director at Cerner, a company that sells electronic health records and billing software to hospitals and doctors' practices. (Cerner lost its Mayo Clinic contract two years ago.)
  • Ellen Zane, former CEO of Tufts Medical Center: board director at medical device company Boston Scientific.
  • Kenneth Samet, CEO of MedStar Health: board director at Evolent Health, a technology and consulting company for hospitals and health plans.
  • Diane Holder, CEO of UPMC Health Plan: board director at Evolent Health.

Go deeper

In photos: How coronavirus is impacting cities around the world

Revellers take part in the "Plague Doctors Procession" in Venice on Tuesday night during the usual period of the Carnival festivities, most of which have been cancelled following the coronavirus outbreak in northern Italy. Photo: Andrea Pattaro/AFP via Getty Images

The novel coronavirus has spread from China to infect people in more than 40 countries and territories around the world, killing over 2,700 people.

The big picture: Most of the 80,000 COVID-19 infections have occurred in mainland China. But cases are starting to surge elsewhere. By Wednesday morning, the worst affected countries outside China were South Korea (1,146), where a U.S. soldier tested positive to the virus, Italy (332), Japan (170), Iran (95) and Singapore (91). Just Tuesday, new cases were confirmed in Switzerland, Croatia and Algeria.

See photosArrow2 hours ago - World

Debate night: Candidates' last face-off before Super Tuesday

Sanders, Biden, Klobuchar and Steyer in South Carolina on Feb. 25. Photo: Jim Watson/AFP via Getty Images

Sen. Bernie Sanders wanted to keep his momentum after winning contests in New Hampshire and Nevada, while former Vice President Joe Biden hoped to keep his own campaign alive. The other five candidates were just trying to hang on.

What's happening: Seven contenders for the Democratic presidential nomination were in Charleston, South Carolina, for the tenth debate, just days before the South Carolina primary and a week before Super Tuesday. They spoke, sometimes over each other, about health care, Russian interference in the election, foreign policy the economy, gun control, marijuana, education, and race.

Go deeperArrowUpdated 5 hours ago - Politics & Policy

4 takeaways from the South Carolina debate

Former Vice President Joe Biden, right, makes a point during Tuesday's Democratic presidential debate, while Vermont Sen. Bernie Sanders listens. Photo: Win McNamee/Getty Images

The 10th Democratic debate was billed as the most consequential of the primary thus far, but Tuesday night's high-stakes affair was at times awkward and unfocused as moderators struggled to rein in candidates desperate to make one last splash before Saturday's primary in South Carolina and Super Tuesday.

The big picture: After cementing himself as the Democratic favorite with a sweeping win in Nevada, Sen. Bernie Sanders came under fire as the front-runner for the first time on the debate stage. Former New York Mayor Michael Bloomberg, who will be on the ballot for the first time next Tuesday, was a progressive foil once again, but he appeared more prepared after taking a drubbing at the Nevada debate.